iron dextran: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
iron dextran: clinical details
Prescribing considerations
- Confirm iron deficiency with appropriate laboratory tests and assess its cause.
- Use only where oral iron is unsuitable or ineffective, or rapid store replenishment is clinically required.
- Reassess benefit and risk with drug allergy, severe asthma, eczema, atopy, systemic lupus erythematosus or rheumatoid arthritis.
- Administer only where staff and facilities for immediate anaphylaxis management are available.
- Previous tolerance of parenteral iron does not exclude subsequent hypersensitivity.
Contraindications and cautions
- Hypersensitivity to iron dextran, the product or an excipient.
- Known serious hypersensitivity to another parenteral iron product.
- Anaemia not caused by iron deficiency.
- Iron overload or impaired iron utilisation.
- Decompensated liver cirrhosis or hepatitis.
- Acute or chronic infection.
- Acute renal failure.
Monitoring
- Check haemoglobin and indices of iron status.
- Monitor closely for hypersensitivity during every administration and for at least 30 minutes afterwards.
- Stop administration immediately if hypersensitivity or intolerance develops.
- Iron dextran can interfere with bilirubin and calcium results and temporarily discolour serum samples.
- During pregnancy, monitor fetal wellbeing during intravenous administration.
Clinical pharmacology
The stable iron(III)-hydroxide dextran complex is taken up by the reticuloendothelial system. Iron is released gradually and incorporated into ferritin, haemosiderin or transferrin for storage and erythropoiesis; excess iron is not readily eliminated.
Formulation and product differences
- The product is a dark-brown solution licensed for intravenous infusion, slow intravenous injection or undiluted intramuscular injection.
- Intravenous infusion is preferred because it may reduce hypotensive episodes.
- For infusion, mix only with the sodium chloride or glucose solutions specified in the product information, and not with other medicines.
- Ampoules are single-use and should be inspected for damage, sediment and loss of homogeneity.
iron dextran interactions
Tell the clinical team about prescribed, non-prescribed and complementary products.
Oral iron preparations
Do not use alongside iron dextran because oral-iron absorption is reduced. The prescriber will advise when oral treatment may resume.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.